50.90
+0.70
+(1.39%)
At close: 1:30:13 PM GMT+8
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-252,236.00
-232,840.00
-97,286.00
-98,919.00
Investing Cash Flow
-109,369.00
175,417.00
-115,762.00
59,442.00
Financing Cash Flow
439,913.00
-1,752.00
287,983.00
4,769.00
End Cash Position
257,851.00
90,195.00
149,370.00
74,435.00
Capital Expenditure
-834.00
-6,587.00
-8,896.00
-4,631.00
Issuance of Capital Stock
446,435.00
4,754.00
294,647.00
9,002.00
Repayment of Debt
-34,735.00
--
--
--
Free Cash Flow
-253,070.00
-239,427.00
-106,182.00
-103,550.00
12/31/2020 - 6/1/2023
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6838.TW Formosa Pharmaceuticals, Inc.
34.00
-0.73%
6885.TW BRIM Biotechnology, Inc.
28.90
-2.03%
6550.TW Polaris Group
43.40
+0.46%
6492.TWO Senhwa Biosciences, Inc.
42.35
+0.47%
6541.TW Tanvex BioPharma, Inc.
65.30
+3.98%
3205.TWO Sagittarius Life Science Corp
33.95
-1.59%
4133.TW Abnova (Taiwan) Corporation
29.80
-1.16%
3176.TWO Medigen Biotechnology Corp.
32.60
-1.21%
6875.TWO Pharmosa Biopharm Inc.
52.90
+1.73%
4162.TWO PharmaEngine, Inc.
95.10
+2.15%